|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 246.60 SEK | -0.40% |
|
+1.82% | -6.90% |
| 04-08 | DNB Carnegie trims AAK price target to SEK 335 (340), reiterates Buy | FW |
| 03-30 | Handelsbanken raises target price for AAK - Buy rating reiterated | FW |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.07 | 5.89 | 5.2 | 8.01 | 9.42 | |||||
Return on Total Capital | 9.39 | 9.54 | 8.21 | 11.74 | 13.48 | |||||
Return On Equity % | 15.69 | 13.42 | 13.23 | 18.32 | 18.98 | |||||
Return on Common Equity | 15.6 | 13.38 | 13.2 | 18.32 | 19.01 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 26.35 | 21.87 | 19.36 | 25.49 | 28.85 | |||||
SG&A Margin | 17 | 13.75 | 12.61 | 15.16 | 16.33 | |||||
EBITDA Margin % | 9.99 | 8.24 | 6.36 | 10.51 | 12.43 | |||||
EBITA Margin % | 7.99 | 6.66 | 5.1 | 9.05 | 10.94 | |||||
EBIT Margin % | 7.85 | 6.57 | 5.05 | 8.98 | 10.87 | |||||
Income From Continuing Operations Margin % | 5.66 | 4.08 | 3.53 | 6.42 | 7.86 | |||||
Net Income Margin % | 5.6 | 4.05 | 3.51 | 6.4 | 7.85 | |||||
Net Avail. For Common Margin % | 5.6 | 4.05 | 3.51 | 6.4 | 7.85 | |||||
Normalized Net Income Margin | 4.56 | 3.9 | 2.9 | 5.2 | 6.45 | |||||
Levered Free Cash Flow Margin | 7.21 | -1.9 | -4.84 | 7.12 | 1.89 | |||||
Unlevered Free Cash Flow Margin | 7.46 | -1.73 | -4.59 | 7.5 | 2.22 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.24 | 1.43 | 1.65 | 1.43 | 1.39 | |||||
Fixed Assets Turnover | 4.26 | 5.62 | 7.23 | 5.8 | 5.35 | |||||
Receivables Turnover (Average Receivables) | 8.14 | 8.37 | 8.57 | 7.71 | 8.11 | |||||
Inventory Turnover (Average Inventory) | 3.11 | 3.55 | 4.02 | 3.46 | 3.12 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.54 | 1.48 | 1.66 | 1.95 | 1.93 | |||||
Quick Ratio | 0.61 | 0.56 | 0.66 | 0.88 | 0.79 | |||||
Operating Cash Flow to Current Liabilities | 0.23 | 0.04 | -0.01 | 0.55 | 0.2 | |||||
Days Sales Outstanding (Average Receivables) | 44.97 | 43.59 | 42.59 | 47.37 | 45.11 | |||||
Days Outstanding Inventory (Average Inventory) | 117.87 | 102.94 | 90.79 | 105.52 | 117.19 | |||||
Average Days Payable Outstanding | 62.73 | 56.57 | 47.07 | 52.5 | 41.12 | |||||
Cash Conversion Cycle (Average Days) | 100.11 | 89.97 | 86.31 | 100.39 | 121.18 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 45.16 | 38.69 | 48.13 | 26.18 | 17.78 | |||||
Total Debt / Total Capital | 31.11 | 27.89 | 32.49 | 20.75 | 15.09 | |||||
LT Debt/Equity | 27.77 | 17.78 | 27.1 | 15.13 | 6.75 | |||||
Long-Term Debt / Total Capital | 19.13 | 12.82 | 18.3 | 11.99 | 5.73 | |||||
Total Liabilities / Total Assets | 56.29 | 56.45 | 55.63 | 43.79 | 41.4 | |||||
EBIT / Interest Expense | 19.25 | 24.02 | 12.54 | 14.77 | 20.83 | |||||
EBITDA / Interest Expense | 25.63 | 31.41 | 16.44 | 17.83 | 24.5 | |||||
(EBITDA - Capex) / Interest Expense | 19.41 | 25.09 | 10.45 | 13.53 | 19.4 | |||||
Total Debt / EBITDA | 1.51 | 1.5 | 2.18 | 0.9 | 0.62 | |||||
Net Debt / EBITDA | 1.09 | 1.17 | 1.72 | 0.6 | 0.29 | |||||
Total Debt / (EBITDA - Capex) | 1.99 | 1.88 | 3.42 | 1.19 | 0.79 | |||||
Net Debt / (EBITDA - Capex) | 1.45 | 1.47 | 2.71 | 0.79 | 0.37 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.02 | 26.91 | 42.23 | -8.72 | -2.12 | |||||
Gross Profit, 1 Yr. Growth % | -5.21 | 5.34 | 25.91 | 20.16 | 10.77 | |||||
EBITDA, 1 Yr. Growth % | 2.46 | 4.73 | 9.68 | 50.9 | 15.79 | |||||
EBITA, 1 Yr. Growth % | 2.86 | 5.69 | 9.07 | 61.81 | 18.32 | |||||
EBIT, 1 Yr. Growth % | 2.43 | 6.2 | 9.27 | 62.41 | 18.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 4.49 | -8.48 | 23.01 | 65.96 | 19.91 | |||||
Net Income, 1 Yr. Growth % | 5.11 | -8.06 | 23.17 | 66.44 | 20.03 | |||||
Normalized Net Income, 1 Yr. Growth % | 3.49 | 8.53 | 5.88 | 63.54 | 21.41 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 5.75 | -8.97 | 22.53 | 66 | 19.56 | |||||
Accounts Receivable, 1 Yr. Growth % | -5.47 | 53.84 | 29.29 | -19.94 | 9.05 | |||||
Inventory, 1 Yr. Growth % | -1.68 | 37.83 | 23.42 | -22.53 | 37.15 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.26 | 0.08 | 20.81 | 8.18 | 4.13 | |||||
Total Assets, 1 Yr. Growth % | -2.8 | 21.94 | 25.12 | -10.12 | 12.55 | |||||
Tangible Book Value, 1 Yr. Growth % | -7.34 | 26.4 | 32.58 | 15.65 | 23.51 | |||||
Common Equity, 1 Yr. Growth % | -6.17 | 21.49 | 27.61 | 13.84 | 17.35 | |||||
Cash From Operations, 1 Yr. Growth % | 29.85 | -74.89 | -114.37 | -7.38K | -55.74 | |||||
Capital Expenditures, 1 Yr. Growth % | -9.91 | -13.54 | 98.21 | -0.82 | -0.58 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 625.08 | -133.4 | 263.28 | -234.13 | -73.99 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 477.75 | -129.35 | 278.55 | -249.04 | -71.06 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.52 | 8.7 | 10 | 34.55 | 35.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.62 | 11.51 | 34.36 | 13.94 | -5.48 | |||||
Gross Profit, 2 Yr. CAGR % | 3.53 | -0.08 | 15.16 | 23 | 15.37 | |||||
EBITDA, 2 Yr. CAGR % | 5.49 | 3.59 | 7.18 | 28.65 | 32.19 | |||||
EBITA, 2 Yr. CAGR % | 6.04 | 4.26 | 7.36 | 32.85 | 38.37 | |||||
EBIT, 2 Yr. CAGR % | 5.91 | 4.3 | 7.72 | 33.22 | 38.67 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.62 | -2.21 | 6.11 | 42.88 | 41.06 | |||||
Net Income, 2 Yr. CAGR % | 8.73 | -1.7 | 6.42 | 43.18 | 41.34 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.41 | 5.98 | 7.19 | 31.59 | 40.91 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.94 | -1.4 | 5.61 | 42.62 | 40.88 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.54 | 20.59 | 41.03 | 1.74 | -6.56 | |||||
Inventory, 2 Yr. CAGR % | 18.16 | 16.41 | 30.42 | -2.22 | 3.08 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.42 | -3.66 | 9.96 | 14.32 | 6.14 | |||||
Total Assets, 2 Yr. CAGR % | 11.14 | 8.87 | 23.52 | 6.05 | 0.58 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.67 | 8.22 | 29.45 | 23.82 | 19.52 | |||||
Common Equity, 2 Yr. CAGR % | 4.35 | 6.77 | 24.51 | 20.53 | 15.58 | |||||
Cash From Operations, 2 Yr. CAGR % | 36.23 | -42.9 | -81 | 223.43 | 467.62 | |||||
Capital Expenditures, 2 Yr. CAGR % | 0.5 | -11.74 | 30.91 | 40.2 | -0.7 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 320.21 | 55.62 | 10.16 | 120.75 | -40.94 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 655.66 | 30.22 | 5.41 | 137.52 | -34.32 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.5 | 9.11 | 9.35 | 21.66 | 34.84 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.85 | 8.71 | 20.93 | 18.11 | 8.32 | |||||
Gross Profit, 3 Yr. CAGR % | 5.78 | 4.13 | 7.93 | 16.8 | 18.78 | |||||
EBITDA, 3 Yr. CAGR % | 7.02 | 5.24 | 5.58 | 20.13 | 24.21 | |||||
EBITA, 3 Yr. CAGR % | 7.15 | 5.92 | 5.84 | 23.1 | 27.82 | |||||
EBIT, 3 Yr. CAGR % | 7.1 | 6.01 | 5.93 | 23.52 | 28.08 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 9.26 | 2.59 | 5.57 | 23.17 | 34.77 | |||||
Net Income, 3 Yr. CAGR % | 9.39 | 2.82 | 5.98 | 23.53 | 35.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | 7.58 | 7.11 | 5.95 | 23.4 | 28.11 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 8.86 | 2.31 | 6 | 22.79 | 34.48 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.29 | 14.25 | 23.42 | 16.77 | 4.12 | |||||
Inventory, 3 Yr. CAGR % | 12.16 | 24.38 | 18.7 | 9.63 | 9.45 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.81 | 4.92 | 3.89 | 9.36 | 10.82 | |||||
Total Assets, 3 Yr. CAGR % | 9.66 | 14.63 | 14.04 | 11.1 | 8.17 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.42 | 10.04 | 15.8 | 24.68 | 23.72 | |||||
Common Equity, 3 Yr. CAGR % | 8.17 | 9.77 | 13.3 | 20.85 | 19.46 | |||||
Cash From Operations, 3 Yr. CAGR % | 22.56 | -22.47 | -63.95 | 37.98 | 66.67 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.13 | -4.42 | 15.58 | 19.34 | 25.03 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 78.28 | 80.68 | 106.44 | 17.63 | 8.22 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 69.86 | 155.91 | 85.85 | 18.31 | 17.76 | |||||
Dividend Per Share, 3 Yr. CAGR % | 12.16 | 10.56 | 9.41 | 17.17 | 25.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.79 | 9.96 | 13.79 | 10.78 | 9.58 | |||||
Gross Profit, 5 Yr. CAGR % | 7.59 | 6.37 | 9.44 | 11.3 | 10.84 | |||||
EBITDA, 5 Yr. CAGR % | 9.59 | 7.05 | 7.08 | 14.04 | 15.51 | |||||
EBITA, 5 Yr. CAGR % | 10.38 | 7.43 | 7.24 | 15.97 | 17.82 | |||||
EBIT, 5 Yr. CAGR % | 9.99 | 7.16 | 7.35 | 16.15 | 17.98 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.84 | 6.83 | 7.99 | 17.13 | 18.54 | |||||
Net Income, 5 Yr. CAGR % | 10.87 | 7.46 | 8.19 | 17.38 | 18.92 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.63 | 9.27 | 7.42 | 16.3 | 18.75 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.45 | 7.14 | 7.76 | 16.85 | 18.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.58 | 11.14 | 15.63 | 9.07 | 10.42 | |||||
Inventory, 5 Yr. CAGR % | 12.79 | 13.3 | 19.13 | 12.97 | 12.19 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 8 | 4.11 | 8.06 | 8.58 | 4.78 | |||||
Total Assets, 5 Yr. CAGR % | 9.9 | 9.59 | 15.01 | 11.12 | 8.45 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.37 | 10.94 | 16.39 | 15.36 | 17.27 | |||||
Common Equity, 5 Yr. CAGR % | 8.01 | 9.39 | 14.43 | 13.95 | 14.21 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.11 | -15.98 | -41.86 | 37.28 | 8.59 | |||||
Capital Expenditures, 5 Yr. CAGR % | -6.06 | -8.69 | 9.27 | 11.41 | 8.77 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 36.62 | 51.68 | 47.05 | 95.75 | 25.14 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 33.86 | 108.23 | 40.35 | 148.39 | 22.59 | |||||
Dividend Per Share, 5 Yr. CAGR % | 12.23 | 11.38 | 11.03 | 14.87 | 18.95 |
- Stock Market
- Equities
- AAK Stock
- Financials AAK AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















